Evidence map›Paper›PMID 23760268›Full record

ArticleThe Journal of biological chemistry2013

Stabilization of the μ-opioid receptor by truncated single transmembrane splice variants through a chaperone-like action.

Jin Xu, Ming Xu, Taylor Brown, Grace C Rossi, Yasmin L Hurd, Charles E Inturrisi, Gavril W Pasternak, Ying-Xian Pan

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Epigenetic Modulation of Opioid Receptors by Drugs of Abuse.International journal of molecular sciences · 2022
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. A "tail" of opioid receptor variants.The Journal of clinical investigation · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Jin XuFrom the Department of Neurology and the Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065.
Ming XuFrom the Department of Neurology and the Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065.
Taylor BrownFrom the Department of Neurology and the Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065.
Grace C Rossithe Department of Psychology, CW Post College, Long Island University, Brookville, New York 11568.
Yasmin L Hurdthe Department of Psychiatry and Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, New York 10029, and.
Charles E Inturrisithe Department of Pharmacology, Weill Cornell Medical College, New York, New York 10065.
Gavril W PasternakFrom the Department of Neurology and the Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065,; the Department of Pharmacology, Weill Cornell Medical College, New York, New York 10065. Electronic address: pasterng@mskcc.org.
Ying-Xian PanFrom the Department of Neurology and the Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065,. Electronic address: pany@mskcc.org.
Memorial Sloan Kettering Cancer Center · USCornell University · USIcahn School of Medicine at Mount Sinai · USPost University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
ULTRASTUCTURE, RECEPTORS, AND GENE EXPRESSIONP60DA005130 · NIDA · ROCKEFELLER UNIVERSITY · PI KREEK, MARY J · 2002 to 2012
$30.6M
TRAINING IN BEHAV. PHARMACOLOGY OF HUMAN DRUG DEPENDENCET32DA007242 · NIDA · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI HEIL, SARAH H, HIGGINS, STEPHEN T · 1990 to 2025
$8.2M
The Opioid mesolimbic system in heroin abuseR01DA015446 · NIDA · KAROLINSKA INSTITUTE · PI HURD, YASMIN L. · 2002 to 2018
$7.1M
Synthesis &Pharmacology of Novel Opiates and SystemsR01DA006241 · NIDA · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI PAN, YING-XIAN · 1990 to 2018
$6.4M
PHARMACOLOGY OF OPIOID RECEPTOR SUBTYPESR01DA007242 · NIDA · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI PAN, YING-XIAN · 1991 to 2022
$6.0M
UNIQUE RNA STRUCTURE OF CAUSATIVE AGENT FOR DELTA HEPATITISP50DA005130 · NIDA · ROCKEFELLER UNIVERSITY · PI KREEK, MARY J · 1987 to 2001
$5.0M
Biochemical Characterization of Opioid ReceptorsR01DA002615 · NIDA · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI PASTERNAK, GAVRIL W · 1985 to 2010
$4.9M
PHARMACOLOGY AND NEUROSCIENCE OF DRUG ABUSET32DA007274 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI SZETO, HAZEL H · 1991 to 2011
$4.8M
REGULATION OF OPIOID PEPTIDE BIOSYNTHESIS AND RELEASER01DA001457 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI INTURRISI, CHARLES E · 1985 to 2008
$3.6M
Characterizing exon 11 promoter of the mu opioid receptor gene, OPRMR01DA013997 · NIDA · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI PAN, YING-XIAN · 2002 to 2012
$3.3M
PHARMACOLOGY OF OPIOID RECEPTOR SUBTYPESR37DA007242 · NIDA · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI PASTERNAK, GAVRIL W · 1996 to 2004
$1.5M
NCI NIH HHS CA08748NCI NIH HHS P30 CA008748NIDA NIH HHS DA013997NIDA NIH HHS DA01457NIDA NIH HHS DA02615NIDA NIH HHS DA029244NIDA NIH HHS DA05130NIDA NIH HHS DA06241NIDA NIH HHS DA07242NIDA NIH HHS DA07274NIDA NIH HHS DA15446NIDA NIH HHS P50 DA005130NIDA NIH HHS P60 DA005130NIDA NIH HHS R01 DA001457NIDA NIH HHS R01 DA002615NIDA NIH HHS R01 DA006241NIDA NIH HHS R01 DA007242NIDA NIH HHS R01 DA013997NIDA NIH HHS R01 DA015446NIDA NIH HHS R21 DA029244NIDA NIH HHS R37 DA007242NIDA NIH HHS R56 DA002615NIDA NIH HHS R56 DA015446NIDA NIH HHS T32 DA007242NIDA NIH HHS T32 DA007274
6 · The paper itself

Abstract

The μ-opioid receptor gene, OPRM1, undergoes extensive alternative pre-mRNA splicing, as illustrated by the identification of an array of splice variants generated by both 5' and 3' alternative splicing. The current study reports the identification of another set of splice variants conserved across species that are generated through exon skipping or insertion that encodes proteins containing only a single transmembrane (TM) domain. Using a Tet-Off system, we demonstrated that the truncated single TM variants can dimerize with the full-length 7-TM μ-opioid receptor (MOR-1) in the endoplasmic reticulum, leading to increased expression of MOR-1 at the protein level by a chaperone-like function that minimizes endoplasmic reticulum-associated degradation. In vivo antisense studies suggested that the single TM variants play an important role in morphine analgesia, presumably through modulation of receptor expression levels. Our studies suggest the functional roles of truncated receptors in other G protein-coupled receptor families.

Indexed as

Alternative SplicingAmino Acid SequenceAnimalsBase SequenceBrefeldin ACell MembraneCloning, MolecularDNA, ComplementaryEndoplasmic ReticulumEnkephalin, Ala(2)-MePhe(4)-Gly(5)-Gene Expression ProfilingGuanosine 5'-O-(3-Thiotriphosphate)HumansMiceMolecular ChaperonesMorphineBrefeldin ADNA, ComplementaryEnkephalin, Ala(2)-MePhe(4)-Gly(5)-Guanosine 5'-O-(3-Thiotriphosphate)Molecular ChaperonesMorphineOligonucleotides, AntisenseReceptors, Opioid, muRNA, MessengerAlternative SplicingAnalgesiaAntisense OligodeoxynucleotideDimerizationG Protein-coupled Receptors (GPCR)Molecular ChaperoneMorphineOpiate OpioidReceptor Regulation

Identifiers

PMID23760268
PMCPMC3774389
OpenAlexW2042989487

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.